Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

Gynuity Health Projects

Status: Completed

Conditions: Medical Abortion, Complete or Unspecified, Without Complication

Treatments: Device: Multi-level pregnancy test

Study type: Interventional

Funder types: Other

Identifiers

NCT03207880

6011

Details and patient eligibility

About

Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services through enabling women to reliably ascertain their abortion outcomes at home sooner than would otherwise have been the case.

safe2choose provides remote medical abortion services through the Internet (information, counselling and access to abortion pills) in a growing number of countries worldwide. safe2choose will collaborate with Gynuity Health Projects to pilot the utility of MLPTs for home follow-up as part of its remote medical abortion services.

As safe2choose does not have a physical office, the location of the sponsor's office is listed in this entry as the study location. Women from the United States are NOT eligible to enroll.

Enrollment: 165 patients

Sex: Female

Ages: Under 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Recipient of safe2choose medical abortion services
• Able to read English or Spanish
• ≤ 56 days LMP
• Willing and able to read and sign consent form
• Agree to comply with the study procedures, including completing the follow-up survey

Exclusion criteria

• Does not meet inclusion criteria

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

165 participants in 1 patient group

MLPT

Experimental group

Description:

Multi-level pregnancy test

Treatment:

Device: Multi-level pregnancy test